R. DURAK, "FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER," 3. International Cancer Days , Sivas, Turkey, pp.314, 2022
DURAK, R. 2022. FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER. 3. International Cancer Days , (Sivas, Turkey), 314.
DURAK, R., (2022). FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER . 3. International Cancer Days (pp.314). Sivas, Turkey
DURAK, RUKİYE. "FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER," 3. International Cancer Days, Sivas, Turkey, 2022
DURAK, RUKİYE. "FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER." 3. International Cancer Days , Sivas, Turkey, pp.314, 2022
DURAK, R. (2022) . "FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER." 3. International Cancer Days , Sivas, Turkey, p.314.
@conferencepaper{conferencepaper, author={RUKİYE ASLAN}, title={FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER}, congress name={3. International Cancer Days}, city={Sivas}, country={Turkey}, year={2022}, pages={314} }